insurance coverage for glp 1 medications of Obesity Therapies in State-Regulated Markets How to Find a Health
Description
Patient uptake estimates that between 25 and 30 million Americans could be using GLP-1 therapies by 2030, up from approximately 10 million in 2026
GLP-1 receptor agonists are typically recommended after trying metformin and other treatments, usually as a third-line option or in specific circumstances such as when weight loss would benefit other obesity-related comorbidities
It was easy and was assisted with what I reached out for
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al
